Kothari Fermentation schedules 36th AGM for September 30, 2026

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Kothari Fermentation & Biochem holds its 36th AGM on September 30, 2026
  • Meeting conducted via VC/OAVM without physical presence
  • Remote e-voting window runs from September 24 to September 29, 2026
  • Eligibility cut-off date for voting is September 23, 2026
powered bylight_fuzz_icon
49707011

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem Limited has scheduled its 36th Annual General Meeting (AGM) for Wednesday, September 30, 2026. The event will be conducted through Video Conference or Other Audio-Visual Means (VC/OAVM) in compliance with Ministry of Corporate Affairs circulars.

The company issued the notice on August 31, 2026, pursuant to Regulation 30 of the SEBI Listing Regulations and the Companies Act, 2013. Electronic copies of the AGM notice and the Annual Report for FY25-26 have been dispatched to members with registered email addresses.

E-Voting Details

Shareholders holding shares as on the cut-off date of September 23, 2026, are eligible to vote. The remote e-voting facility is provided by National Securities Depository Limited (NSDL).

Particulars Details
Cut-off Date September 23, 2026
Voting Start September 24, 2026 at 9:00 am
Voting End September 29, 2026 at 5:00 pm

Members who have not cast their votes via remote e-voting may vote during the AGM. Those who voted remotely cannot vote again during the meeting.

Shareholder Updates

Physical shareholders are requested to update their email addresses by submitting Form ISR-1 to Abhipra Capital Limited. Demat holders must update details with their respective Depository Participants. Physical copies of the notice can be requested from the company or RTA.

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
+2.76%+1.14%-4.42%+12.61%-12.88%0.0%

What specific financial performance metrics and strategic initiatives for FY25-26 are likely to be highlighted in the Annual Report?

How might the outcomes of the AGM resolutions impact Kothari Fermentation's future capital allocation or dividend policy?

Are there any pending regulatory compliance issues or auditor qualifications mentioned in the notice that could affect investor confidence?

Kothari Fermentation & Biochem
View Company Insights
View All News
like20
dislike

Kothari Fermentation & Biochem Q1FY27 Results: Net profit rises to ₹1.63 crore

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Kothari Fermentation and Biochem Ltd posted a net profit of ₹162.64 lakh in Q1FY27, reversing a loss of ₹61.23 lakh in Q1FY26. Revenue from operations rose to ₹110.16 lakh. The company also reminded investors of the special window for physical share demat, closing February 4, 2027.

powered bylight_fuzz_icon
47374063

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation and Biochem Ltd reported a net profit of ₹162.64 lakh for the quarter ended June 30, 2026 (Q1FY27), marking a return to profitability from a net loss of ₹61.23 lakh in the corresponding period of FY26. The company also issued its third reminder to shareholders regarding the one-time special window for the transfer and dematerialisation of physical shares, which remains open until February 4, 2027, pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026.

The financial results were reviewed by the Audit Committee and approved by the Board of Directors on July 31, 2026. The statutory auditor expressed an unmodified review opinion on the consolidated financial results. These results are prepared in accordance with Indian Accounting Standards (Ind AS) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

Revenue from operations surged to ₹110.16 lakh in Q1FY27, compared to ₹26.32 lakh in Q1FY26. Total income, including other income, stood at ₹6,653.59 lakh, driven largely by non-operating sources. Total expenses were ₹6,429.21 lakh, resulting in a profit from operations before exceptional items of ₹224.38 lakh.

Particulars Q1FY27 (₹ Lakh) Q1FY26 (₹ Lakh) YoY Change
Revenue from Operations 110.16 26.32 +318.5%
Other Income 6,653.59 2,241.18 +196.9%
Total Expenses 6,429.21 2,318.57 +177.3%
Profit Before Tax 224.38 (77.39) Turnaround
Net Profit After Tax 162.64 (61.23) Turnaround

Key Operational Updates

The company allotted 398,800 fully convertible warrants on a preferential basis during the quarter at an issue price of ₹115 per warrant, aggregating to ₹458.62 lakh. Each warrant is convertible into one equity share of face value ₹10 within 18 months from the date of allotment. As of June 30, 2026, no warrants had been converted into equity shares.

Regarding the special window for share transfer, eligible investors are requested to lodge their requests with the company’s RTA, Abhipra Capital Ltd, along with original share certificates and duly executed transfer deeds dated prior to April 1, 2019. Investors are advised to ensure their demat account and KYC details are updated to avoid processing delays.

What the Numbers Show

The significant divergence between revenue from operations (₹110.16 lakh) and total income (₹6,653.59 lakh) indicates that the majority of the company’s income in Q1FY27 was derived from other income rather than core operations. While operational revenue grew substantially year-on-year, the profit before tax of ₹224.38 lakh is heavily influenced by this other income component, suggesting that core operational profitability remains a smaller fraction of the total bottom line.

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
+2.76%+1.14%-4.42%+12.61%-12.88%0.0%

What specific non-operating activities drove the 196.9% surge in other income, and is this level of income sustainable for future quarters?

How will the conversion of the recently allotted fully convertible warrants impact the company's equity base and earnings per share within the next 18 months?

Given that core operational revenue remains a small fraction of total income, what strategic initiatives are planned to improve profitability from primary business operations?

Kothari Fermentation & Biochem
View Company Insights
View All News
like20
dislike

More News on Kothari Fermentation & Biochem

1 Year Returns:-12.88%